Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
7,846
Views
12
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination

Takeru Kashiwadaa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Yoshinobu Saitoa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanCorrespondence[email protected]
View further author information
,
Yasuhiro Terasakib Department of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Yukari Shirakuraa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Kaoruko Shinbua Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Toru Tanakaa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Yosuke Tanakaa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
,
Masahiro Seikea Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
&
Akihiko Gemmaa Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanView further author information
 show all
Article: 2071080 | Received 21 Mar 2022, Accepted 25 Apr 2022, Published online: 18 May 2022

References

  • El-Sayed MS, Wechie GN, Low CS, Adesanya O, Rao N, Leung VJ. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT. Clin Med (Lond). 2021;21:e633–4. doi:10.7861/clinmed.2021-0420.
  • Park JY, Lee JY, Yi SY. Axillary lymphadenopathy on ultrasound after COVID-19 vaccination and its influencing factors: a single-center study. J Clin Med. 2022;11(1):238. doi:10.3390/jcm11010238.
  • Perry AM, Choi SM. Kikuchi-Fujimoto disease: a review. Arch Pathol Lab Med. 2018;142:1341–46. doi:10.5858/arpa.2018-0219-RA.
  • Soub HA, Ibrahim W, Maslamani MA, Ali GA, Ummer W, Abu-Dayeh A. Kikuchi-Fujimoto disease following SARS CoV2 vaccination: case report. Idcases. 2021;25:e01253. doi:10.1016/j.idcr.2021.e01253.
  • Tan HM, Hue SS, Wee A, See KC. Kikuchi-Fujimoto disease post COVID-19 vaccination: case report and review of literature. Vaccines (Basel). 2021;9(11):1251. doi:10.3390/vaccines9111251.
  • Caocci G, Fanni D, Porru M, Greco M, Nemolato S, Firinu D, Faa G, Scuteri A, La Nasa G. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination. Haematologica; 2021; Dec 30. Advance online publication. doi:10.3324/haematol.2021.280239.
  • Tu W, Gierada DS, Joe BN. COVID-19 vaccination-related lymphadenopathy: what to be aware of. Radiol Imaging Cancer. 2021;3:e210038. doi:10.1148/rycan.2021210038.
  • Lam DL, Flanagan MR. Axillary lymphadenopathy after COVID-19 vaccination in a woman with breast cancer. Jama. 2022;327:175–76. doi:10.1001/jama.2021.20010.
  • Watanabe T, Hashidate H, Hirayama Y, Iinuma Y. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis. Eur J Pediatr. 2012;171:1409–11. doi:10.1007/s00431-012-1729-1.
  • Masiak A, Lass A, Kowalski J, Hajduk A, Zdrojewski Z. Self-Limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case-based review. Rheumatol Int. 2022;42:341–48. doi:10.1007/s00296-021-05088-8.
  • Al Ghadeer HA, AlKadhem SM, AlMajed MS, AlAmer HM, AlHabeeb JA, Alomran SH, AlMajed AS. Kikuchi-Fujimoto disease following COVID-19. Cureus. 2022;14:e21049.
  • Stimson L, Stitson R, Bahhadi-Hardo M, Renaudon-Smith E. COVID-19 associated Kikuchi-Fujimoto disease. Br J Haematol. 2021;192:e124–e126. doi:10.1111/bjh.17292.
  • Racette SD, Alexiev BA, Angarone MP, Bhasin A, Lima K, Jennings LJ, Balasubramanian S, Matsuoka AJ. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report. BMC Infect Dis. 2021;21:740. doi:10.1186/s12879-021-06048-0.
  • Jaseb K, Nameh Goshay Fard N, Rezaei N, Sadeghian S, Sadeghian S. COVID-19 in a case with Kikuchi-Fujimoto disease. Clin Case Rep. 2021;9:1279–82. doi:10.1002/ccr3.3748.
  • Chen LC, Wang CJ, Chang YC, Shie SS, Lin TY, Hsieh YC, Huang KYA, Kuo CY, Chiu CH, Huang YC, et al. Distribution of lymphadenopathy in patients with Kikuchi disease. J Microbiol Immunol Infect. 2021;54:299–304. doi:10.1016/j.jmii.2019.08.016.
  • Al-Maghrabi J, Kanaan H. Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) in Saudi Arabia: clinicopathology and immunohistochemistry. Ann Saudi Med. 2005;25:319–23. doi:10.5144/0256-4947.2005.319.
  • Masab M, Surmachevska N, Farooq H. Kikuchi disease. Treasure Island (FL): StatPearls Publishing LLC; 2022.
  • Liang F, Lindgren G, Lin A, Thompson EA, Ols S, Röhss J, John S, Hassett K, Yuzhakov O, Bahl K, et al. Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in rhesus macaques. Mol Ther. 2017;25:2635–47. doi:10.1016/j.ymthe.2017.08.006.
  • Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586:594–99. doi:10.1038/s41586-020-2814-7.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.